In conclusion, nucleostemin and ASPP2 were expressed in pituitary adenoma tissues and were associated with the aggressive behavior and proliferation activity of the tumor, indicating that these factors play a significant role in pituitary adenoma oncogenesis and tumor progression, and have the potential to be a target for pituitary adenoma gene therapy. Here, GNL3 is linked to pituitary gland adenoma.